Mustang Bio, Inc.
MBIO
$0.59
$0.00-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 946.00K | 880.00K | 987.00K | 957.00K | 787.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.17M | 1.06M | 670.00K | 624.00K | 885.00K |
| Operating Income | -1.17M | -1.06M | -670.00K | -624.00K | -885.00K |
| Income Before Tax | -1.07M | -955.00K | -538.00K | -468.00K | -762.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.07M | -955.00K | -538.00K | -468.00K | -762.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.07M | -955.00K | -538.00K | -468.00K | -762.00K |
| EBIT | -1.17M | -1.06M | -670.00K | -624.00K | -885.00K |
| EBITDA | -1.16M | -1.05M | -670.00K | -624.00K | -885.00K |
| EPS Basic | -0.16 | -0.14 | -0.08 | -0.08 | -0.19 |
| Normalized Basic EPS | -0.10 | -0.09 | -0.05 | -0.05 | -0.12 |
| EPS Diluted | -0.16 | -0.14 | -0.08 | -0.08 | -0.19 |
| Normalized Diluted EPS | -0.10 | -0.09 | -0.05 | -0.05 | -0.12 |
| Average Basic Shares Outstanding | 6.73M | 6.73M | 6.47M | 6.24M | 4.02M |
| Average Diluted Shares Outstanding | 6.73M | 6.73M | 6.47M | 6.24M | 4.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |